Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease

KANİ H. T., DEMİRTAŞ C. Ö., KEKLİKKIRAN Ç., Ergenc I., Mehdiyev S., AKDENİZ E., ...Daha Fazla

TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.32, sa.8, ss.661-666, 2021 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 8
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5152/tjg.2021.20512
  • Dergi Adı: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.661-666
  • Anahtar Kelimeler: Fibrosis, metabolic syndrome, metabolic dysfunction-associated fatty liver disease, SEVERITY, STEATOHEPATITIS, PROGRESSION, OUTCOMES, NAFLD
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Hayır

Özet

Background: Metabolic syndrome (MS) is a condition that consists of several disorders, and the individual impact of these disorders on metabolic dysfunction-associated fatty liver disease (MAFLD) is still not clear in a combined diagnosis of MS. In this study, we aimed to investigate the effect of MS on advanced fibrosis in patients with MAFLD.